Listed

Kraig Biocraft Laboratories, Inc.

KBLBOTCCIK 1413119MaterialsFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$703.4k, Q2 FY2026
Net income−$909.5k, Q2 FY2026
Kraig Biocraft Laboratories, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$knot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Research and development$k39.1Research and development, Q3 FY2023, three months to 2023-09-30$39.1k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-13, accession 0001493152-24-045153.Report this figure72.6Research and development, Q4 FY2023, three months to 2023-12-31$72.6k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-28, accession 0001641172-25-001238. Derived: 12-month figure less the 9-month figure.Report this figure29.4Research and development, Q1 FY2024, three months to 2024-03-31$29.4k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-15, accession 0001641172-25-010985.Report this figure49.4Research and development, Q2 FY2024, three months to 2024-06-30$49.4k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-14, accession 0001493152-25-011968.Report this figure25.0Research and development, Q3 FY2024, three months to 2024-09-30$25.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001493152-25-021953.Report this figure60.6Research and development, Q4 FY2024, three months to 2024-12-31$60.6k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-30, accession 0001493152-26-013630. Derived: 12-month figure less the 9-month figure.Report this figure23.9Research and development, Q1 FY2025, three months to 2025-03-31$23.9k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-14, accession 0001493152-26-023130.Report this figure63.9Research and development, Q2 FY2025, three months to 2025-06-30$63.9k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001493152-26-037818.Report this figure9.2Research and development, Q3 FY2025, three months to 2025-09-30$9.2k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001493152-25-021953.Report this figure68.8Research and development, Q4 FY2025, three months to 2025-12-31$68.8k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-30, accession 0001493152-26-013630. Derived: 12-month figure less the 9-month figure.Report this figure66.7Research and development, Q1 FY2026, three months to 2026-03-31$66.7k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-14, accession 0001493152-26-023130.Report this figure64.4Research and development, Q2 FY2026, three months to 2026-06-30$64.4k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001493152-26-037818.Report this figure
Operating income$k(459)Operating income, Q3 FY2023, three months to 2023-09-30−$459.4k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-13, accession 0001493152-24-045153.Report this figure(1,188)Operating income, Q4 FY2023, three months to 2023-12-31−$1.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-28, accession 0001641172-25-001238. Derived: 12-month figure less the 9-month figure.Report this figure(449)Operating income, Q1 FY2024, three months to 2024-03-31−$448.7k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-15, accession 0001641172-25-010985.Report this figure(1,486)Operating income, Q2 FY2024, three months to 2024-06-30−$1.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-14, accession 0001493152-25-011968.Report this figure(424)Operating income, Q3 FY2024, three months to 2024-09-30−$423.8k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001493152-25-021953.Report this figure(716)Operating income, Q4 FY2024, three months to 2024-12-31−$715.9k. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-30, accession 0001493152-26-013630. Derived: 12-month figure less the 9-month figure.Report this figure(580)Operating income, Q1 FY2025, three months to 2025-03-31−$580.5k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001493152-26-023130.Report this figure(638)Operating income, Q2 FY2025, three months to 2025-06-30−$637.7k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001493152-26-037818.Report this figure(1,434)Operating income, Q3 FY2025, three months to 2025-09-30−$1.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001493152-25-021953.Report this figure(723)Operating income, Q4 FY2025, three months to 2025-12-31−$722.7k. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-30, accession 0001493152-26-013630. Derived: 12-month figure less the 9-month figure.Report this figure(826)Operating income, Q1 FY2026, three months to 2026-03-31−$825.5k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001493152-26-023130.Report this figure(703)Operating income, Q2 FY2026, three months to 2026-06-30−$703.4k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001493152-26-037818.Report this figure
Interest expense$k122Interest expense, Q3 FY2023, three months to 2023-09-30$122.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2024-11-13, accession 0001493152-24-045153.Report this figure126Interest expense, Q4 FY2023, three months to 2023-12-31$125.6k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2025-03-28, accession 0001641172-25-001238. Derived: 12-month figure less the 9-month figure.Report this figure130Interest expense, Q1 FY2024, three months to 2024-03-31$129.9k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-05-15, accession 0001641172-25-010985.Report this figure131Interest expense, Q2 FY2024, three months to 2024-06-30$130.9k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-08-14, accession 0001493152-25-011968.Report this figure133Interest expense, Q3 FY2024, three months to 2024-09-30$132.9k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-12, accession 0001493152-25-021953.Report this figure136Interest expense, Q4 FY2024, three months to 2024-12-31$135.9k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-30, accession 0001493152-26-013630. Derived: 12-month figure less the 9-month figure.Report this figure140Interest expense, Q1 FY2025, three months to 2025-03-31$140.3k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-14, accession 0001493152-26-023130.Report this figure142Interest expense, Q2 FY2025, three months to 2025-06-30$142.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-13, accession 0001493152-26-037818.Report this figure144Interest expense, Q3 FY2025, three months to 2025-09-30$144.3k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-12, accession 0001493152-25-021953.Report this figure144Interest expense, Q4 FY2025, three months to 2025-12-31$144.1k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-30, accession 0001493152-26-013630. Derived: 12-month figure less the 9-month figure.Report this figure148Interest expense, Q1 FY2026, three months to 2026-03-31$148.4k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-14, accession 0001493152-26-023130.Report this figure151Interest expense, Q2 FY2026, three months to 2026-06-30$151.4k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-13, accession 0001493152-26-037818.Report this figure
Income tax$knot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Net income$k(549)Net income, Q3 FY2023, three months to 2023-09-30−$549.3k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-13, accession 0001493152-24-045153.Report this figure(1,325)Net income, Q4 FY2023, three months to 2023-12-31−$1.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-28, accession 0001641172-25-001238. Derived: 12-month figure less the 9-month figure.Report this figure(508)Net income, Q1 FY2024, three months to 2024-03-31−$507.9k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-15, accession 0001641172-25-010985.Report this figure(1,606)Net income, Q2 FY2024, three months to 2024-06-30−$1.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-14, accession 0001493152-25-011968.Report this figure(433)Net income, Q3 FY2024, three months to 2024-09-30−$433.2k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001493152-25-021953.Report this figure(852)Net income, Q4 FY2024, three months to 2024-12-31−$851.7k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-30, accession 0001493152-26-013630. Derived: 12-month figure less the 9-month figure.Report this figure(600)Net income, Q1 FY2025, three months to 2025-03-31−$600.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-14, accession 0001493152-26-023130.Report this figure(726)Net income, Q2 FY2025, three months to 2025-06-30−$726.1k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001493152-26-037818.Report this figure(1,510)Net income, Q3 FY2025, three months to 2025-09-30−$1.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001493152-25-021953.Report this figure(788)Net income, Q4 FY2025, three months to 2025-12-31−$787.6k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-30, accession 0001493152-26-013630. Derived: 12-month figure less the 9-month figure.Report this figure(943)Net income, Q1 FY2026, three months to 2026-03-31−$942.7k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-14, accession 0001493152-26-023130.Report this figure(910)Net income, Q2 FY2026, three months to 2026-06-30−$909.5k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001493152-26-037818.Report this figure
Diluted EPS$ per share0.00Diluted EPS, Q3 FY2023, three months to 2023-09-30$0.00 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-13, accession 0001493152-24-045153.Report this figurenot reported0.00Diluted EPS, Q1 FY2024, three months to 2024-03-31$0.00 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-15, accession 0001641172-25-010985.Report this figure0.00Diluted EPS, Q2 FY2024, three months to 2024-06-30$0.00 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-14, accession 0001493152-25-011968.Report this figure0.00Diluted EPS, Q3 FY2024, three months to 2024-09-30$0.00 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001493152-25-021953.Report this figurenot reported0.00Diluted EPS, Q1 FY2025, three months to 2025-03-31$0.00 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001493152-26-023130.Report this figure0.00Diluted EPS, Q2 FY2025, three months to 2025-06-30$0.00 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001493152-26-037818.Report this figure0.00Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.00 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001493152-25-021953.Report this figurenot reported0.00Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.00 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001493152-26-023130.Report this figure0.00Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.00 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001493152-26-037818.Report this figure
Basic EPS$ per share0.00Basic EPS, Q3 FY2023, three months to 2023-09-30$0.00 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-13, accession 0001493152-24-045153.Report this figurenot reported0.00Basic EPS, Q1 FY2024, three months to 2024-03-31$0.00 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-15, accession 0001641172-25-010985.Report this figure0.00Basic EPS, Q2 FY2024, three months to 2024-06-30$0.00 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-14, accession 0001493152-25-011968.Report this figure0.00Basic EPS, Q3 FY2024, three months to 2024-09-30$0.00 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001493152-25-021953.Report this figurenot reported0.00Basic EPS, Q1 FY2025, three months to 2025-03-31$0.00 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0001493152-26-023130.Report this figure0.00Basic EPS, Q2 FY2025, three months to 2025-06-30$0.00 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001493152-26-037818.Report this figure0.00Basic EPS, Q3 FY2025, three months to 2025-09-30$0.00 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001493152-25-021953.Report this figurenot reported0.00Basic EPS, Q1 FY2026, three months to 2026-03-31$0.00 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0001493152-26-023130.Report this figure0.00Basic EPS, Q2 FY2026, three months to 2026-06-30$0.00 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001493152-26-037818.Report this figure

Balance sheet

Cash and equivalents$3.4m, Q2 FY2026
Shareholders' equity−$6.8m, Q2 FY2026
Kraig Biocraft Laboratories, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m2.9Cash and equivalents, Q3 FY2023, at 2023-09-30$2.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-13, accession 0001493152-23-040575.Report this figure2.6Cash and equivalents, FY2023, at 2023-12-31$2.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-28, accession 0001641172-25-001238.Report this figure2.0Cash and equivalents, Q1 FY2024, at 2024-03-31$2.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-14, accession 0001493152-24-019270.Report this figure1.5Cash and equivalents, Q2 FY2024, at 2024-06-30$1.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-14, accession 0001493152-24-032266.Report this figure1.2Cash and equivalents, Q3 FY2024, at 2024-09-30$1.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-13, accession 0001493152-24-045153.Report this figure0.7Cash and equivalents, FY2024, at 2024-12-31$673.3k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-30, accession 0001493152-26-013630.Report this figure0.4Cash and equivalents, Q1 FY2025, at 2025-03-31$397.0k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-15, accession 0001641172-25-010985.Report this figure0.8Cash and equivalents, Q2 FY2025, at 2025-06-30$785.5k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-14, accession 0001493152-25-011968.Report this figure1.6Cash and equivalents, Q3 FY2025, at 2025-09-30$1.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-12, accession 0001493152-25-021953.Report this figure1.8Cash and equivalents, FY2025, at 2025-12-31$1.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001493152-26-037818.Report this figure2.9Cash and equivalents, Q1 FY2026, at 2026-03-31$2.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-14, accession 0001493152-26-023130.Report this figure3.4Cash and equivalents, Q2 FY2026, at 2026-06-30$3.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001493152-26-037818.Report this figure
Current assets$m3.0Current assets, Q3 FY2023, at 2023-09-30$3.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-13, accession 0001493152-23-040575.Report this figure2.6Current assets, FY2023, at 2023-12-31$2.6m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-28, accession 0001641172-25-001238.Report this figure2.1Current assets, Q1 FY2024, at 2024-03-31$2.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-14, accession 0001493152-24-019270.Report this figure1.5Current assets, Q2 FY2024, at 2024-06-30$1.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-14, accession 0001493152-24-032266.Report this figure1.2Current assets, Q3 FY2024, at 2024-09-30$1.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-13, accession 0001493152-24-045153.Report this figure0.7Current assets, FY2024, at 2024-12-31$740.3k. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-30, accession 0001493152-26-013630.Report this figure0.5Current assets, Q1 FY2025, at 2025-03-31$452.7k. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-15, accession 0001641172-25-010985.Report this figure0.8Current assets, Q2 FY2025, at 2025-06-30$839.0k. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-14, accession 0001493152-25-011968.Report this figure1.6Current assets, Q3 FY2025, at 2025-09-30$1.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-12, accession 0001493152-25-021953.Report this figure1.9Current assets, FY2025, at 2025-12-31$1.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001493152-26-037818.Report this figure3.0Current assets, Q1 FY2026, at 2026-03-31$3.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-14, accession 0001493152-26-023130.Report this figure3.6Current assets, Q2 FY2026, at 2026-06-30$3.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001493152-26-037818.Report this figure
Total assets$m3.6Total assets, Q3 FY2023, at 2023-09-30$3.6m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-13, accession 0001493152-23-040575.Report this figure3.2Total assets, FY2023, at 2023-12-31$3.2m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-28, accession 0001641172-25-001238.Report this figure2.8Total assets, Q1 FY2024, at 2024-03-31$2.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-14, accession 0001493152-24-019270.Report this figure2.2Total assets, Q2 FY2024, at 2024-06-30$2.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-14, accession 0001493152-24-032266.Report this figure2.0Total assets, Q3 FY2024, at 2024-09-30$2.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-13, accession 0001493152-24-045153.Report this figure1.5Total assets, FY2024, at 2024-12-31$1.5m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-30, accession 0001493152-26-013630.Report this figure1.3Total assets, Q1 FY2025, at 2025-03-31$1.3m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-14, accession 0001493152-26-023130.Report this figure1.6Total assets, Q2 FY2025, at 2025-06-30$1.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001493152-26-037818.Report this figure2.4Total assets, Q3 FY2025, at 2025-09-30$2.4m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-12, accession 0001493152-25-021953.Report this figure2.6Total assets, FY2025, at 2025-12-31$2.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001493152-26-037818.Report this figure3.7Total assets, Q1 FY2026, at 2026-03-31$3.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-14, accession 0001493152-26-023130.Report this figure4.3Total assets, Q2 FY2026, at 2026-06-30$4.3m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001493152-26-037818.Report this figure
Current liabilities$m8.6Current liabilities, Q3 FY2023, at 2023-09-30$8.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-13, accession 0001493152-23-040575.Report this figure8.9Current liabilities, FY2023, at 2023-12-31$8.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-28, accession 0001641172-25-001238.Report this figure9.0Current liabilities, Q1 FY2024, at 2024-03-31$9.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-14, accession 0001493152-24-019270.Report this figure9.1Current liabilities, Q2 FY2024, at 2024-06-30$9.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-14, accession 0001493152-24-032266.Report this figure9.3Current liabilities, Q3 FY2024, at 2024-09-30$9.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-13, accession 0001493152-24-045153.Report this figure9.6Current liabilities, FY2024, at 2024-12-31$9.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-30, accession 0001493152-26-013630.Report this figure9.8Current liabilities, Q1 FY2025, at 2025-03-31$9.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-15, accession 0001641172-25-010985.Report this figure10.0Current liabilities, Q2 FY2025, at 2025-06-30$10.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-14, accession 0001493152-25-011968.Report this figure10.2Current liabilities, Q3 FY2025, at 2025-09-30$10.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-12, accession 0001493152-25-021953.Report this figure10.4Current liabilities, FY2025, at 2025-12-31$10.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001493152-26-037818.Report this figure10.7Current liabilities, Q1 FY2026, at 2026-03-31$10.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-14, accession 0001493152-26-023130.Report this figure10.9Current liabilities, Q2 FY2026, at 2026-06-30$10.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001493152-26-037818.Report this figure
Total liabilities$m8.6Total liabilities, Q3 FY2023, at 2023-09-30$8.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-13, accession 0001493152-23-040575.Report this figure8.9Total liabilities, FY2023, at 2023-12-31$8.9m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-28, accession 0001641172-25-001238.Report this figure9.0Total liabilities, Q1 FY2024, at 2024-03-31$9.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-14, accession 0001493152-24-019270.Report this figure9.2Total liabilities, Q2 FY2024, at 2024-06-30$9.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-14, accession 0001493152-24-032266.Report this figure9.4Total liabilities, Q3 FY2024, at 2024-09-30$9.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-13, accession 0001493152-24-045153.Report this figure9.7Total liabilities, FY2024, at 2024-12-31$9.7m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-30, accession 0001493152-26-013630.Report this figure9.9Total liabilities, Q1 FY2025, at 2025-03-31$9.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-15, accession 0001641172-25-010985.Report this figure10.1Total liabilities, Q2 FY2025, at 2025-06-30$10.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-14, accession 0001493152-25-011968.Report this figure10.3Total liabilities, Q3 FY2025, at 2025-09-30$10.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-12, accession 0001493152-25-021953.Report this figure10.6Total liabilities, FY2025, at 2025-12-31$10.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001493152-26-037818.Report this figure10.8Total liabilities, Q1 FY2026, at 2026-03-31$10.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-14, accession 0001493152-26-023130.Report this figure11.0Total liabilities, Q2 FY2026, at 2026-06-30$11.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001493152-26-037818.Report this figure
Long-term debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m(5.0)Shareholders' equity, Q3 FY2023, at 2023-09-30−$5.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-13, accession 0001493152-24-045153.Report this figure(5.7)Shareholders' equity, FY2023, at 2023-12-31−$5.7m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-30, accession 0001493152-26-013630.Report this figure(6.2)Shareholders' equity, Q1 FY2024, at 2024-03-31−$6.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-14, accession 0001493152-25-011968.Report this figure(7.0)Shareholders' equity, Q2 FY2024, at 2024-06-30−$7.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001493152-25-021953.Report this figure(7.4)Shareholders' equity, Q3 FY2024, at 2024-09-30−$7.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001493152-25-021953.Report this figure(8.1)Shareholders' equity, FY2024, at 2024-12-31−$8.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001493152-26-037818.Report this figure(8.5)Shareholders' equity, Q1 FY2025, at 2025-03-31−$8.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001493152-26-037818.Report this figure(8.5)Shareholders' equity, Q2 FY2025, at 2025-06-30−$8.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001493152-26-037818.Report this figure(8.0)Shareholders' equity, Q3 FY2025, at 2025-09-30−$8.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001493152-25-021953.Report this figure(8.0)Shareholders' equity, FY2025, at 2025-12-31−$8.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001493152-26-037818.Report this figure(7.1)Shareholders' equity, Q1 FY2026, at 2026-03-31−$7.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001493152-26-037818.Report this figure(6.8)Shareholders' equity, Q2 FY2026, at 2026-06-30−$6.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001493152-26-037818.Report this figure

Cash flow

Operating cash flow−$598.7k, Q2 FY2026
Capital expenditure$28.6k, Q2 FY2026
Kraig Biocraft Laboratories, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$k(249)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$248.7k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-13, accession 0001493152-24-045153. Derived: 9-month figure less the 6-month figure.Report this figure(328)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$327.7k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-28, accession 0001641172-25-001238. Derived: 12-month figure less the 9-month figure.Report this figure(490)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$489.5k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-15, accession 0001641172-25-010985.Report this figure(511)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$510.8k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-14, accession 0001493152-25-011968. Derived: 6-month figure less the 3-month figure.Report this figure(326)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$326.3k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001493152-25-021953. Derived: 9-month figure less the 6-month figure.Report this figure(513)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$512.5k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-30, accession 0001493152-26-013630. Derived: 12-month figure less the 9-month figure.Report this figure(434)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$434.5k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001493152-26-023130.Report this figure(443)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$443.1k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001493152-26-037818. Derived: 6-month figure less the 3-month figure.Report this figure(462)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$461.9k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001493152-25-021953. Derived: 9-month figure less the 6-month figure.Report this figure(449)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$449.5k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-30, accession 0001493152-26-013630. Derived: 12-month figure less the 9-month figure.Report this figure(530)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$529.7k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001493152-26-023130.Report this figure(599)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$598.7k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001493152-26-037818. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$knot reported0.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-28, accession 0001641172-25-001238. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reported0.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001493152-25-021953. Derived: 9-month figure less the 6-month figure.Report this figure1.6Capital expenditure, Q4 FY2025, three months to 2025-12-31$1.6k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-30, accession 0001493152-26-013630. Derived: 12-month figure less the 9-month figure.Report this figure14.1Capital expenditure, Q1 FY2026, three months to 2026-03-31$14.1k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-14, accession 0001493152-26-023130.Report this figure28.6Capital expenditure, Q2 FY2026, three months to 2026-06-30$28.6k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001493152-26-037818. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)1.11bn, Q2 FY2026
Kraig Biocraft Laboratories, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares977Diluted shares (weighted), Q3 FY2022, three months to 2022-09-30976,587,869 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-13, accession 0001493152-23-040575.Report this figure1,032Diluted shares (weighted), Q1 FY2023, three months to 2023-03-311,032,075,973 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-14, accession 0001493152-24-019270.Report this figure1,033Diluted shares (weighted), Q2 FY2023, three months to 2023-06-301,033,374,219 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-14, accession 0001493152-24-032266.Report this figure1,033Diluted shares (weighted), Q3 FY2023, three months to 2023-09-301,033,374,219 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-13, accession 0001493152-24-045153.Report this figure1,038Diluted shares (weighted), Q1 FY2024, three months to 2024-03-311,038,374,219 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-15, accession 0001641172-25-010985.Report this figure1,038Diluted shares (weighted), Q2 FY2024, three months to 2024-06-301,038,374,219 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-14, accession 0001493152-25-011968.Report this figure1,038Diluted shares (weighted), Q3 FY2024, three months to 2024-09-301,038,374,219 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001493152-25-021953.Report this figure1,041Diluted shares (weighted), Q1 FY2025, three months to 2025-03-311,041,458,063 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-14, accession 0001493152-26-023130.Report this figure1,047Diluted shares (weighted), Q2 FY2025, three months to 2025-06-301,047,493,242 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001493152-26-037818.Report this figure1,068Diluted shares (weighted), Q3 FY2025, three months to 2025-09-301,068,264,462 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001493152-25-021953.Report this figure1,091Diluted shares (weighted), Q1 FY2026, three months to 2026-03-311,090,869,198 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-14, accession 0001493152-26-023130.Report this figure1,110Diluted shares (weighted), Q2 FY2026, three months to 2026-06-301,110,343,050 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001493152-26-037818.Report this figure

Shares outstanding: 1.10bnShares outstanding, Q1 FY2026, at 2026-03-301,099,791,733 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-K filed 2026-03-30, accession 0001493152-26-013630.Report this figure at Mar 30, 2026, from the cover of the 10-K filed Mar 30, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. Listed shows no prices and gives no investment advice.